Maximizing dendritic cell migration in cancer immunotherapy
- 12 June 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Biological Therapy
- Vol. 8 (7), 865-874
- https://doi.org/10.1517/14712598.8.7.865
Abstract
Background: The success of dendritic cell (DC)-based immunotherapy in inducing cellular immunity against tumors is highly dependent on accurate delivery and trafficking of the DC to T-cell-rich areas of secondary lymphoid tissues. Objective: To provide an overview of DC migration in vivo and how migration to peripheral lymph nodes might be improved to optimize DC therapy. Methods: We focused on DC migration in preclinical models and human skin explants and on clinical vaccination trials studying migration of in vitro-generated DC. Results/conclusions: DC migration requires an intricate interplay between the cell and its environment. To maximize migration for cellular therapy, it is important to optimize the generation of migratory DC as well as treatment strategies.Keywords
This publication has 74 references indexed in Scilit:
- Plasticity of dendritic cell function in response to prostaglandin E2 (PGE2) and interferon-γ (IFN-γ)Journal of Leukocyte Biology, 2008
- Monocytes Immunoselected via the Novel Monocyte Specific Molecule, CD300e, Differentiate Into Active Migratory Dendritic CellsJournal of Immunotherapy, 2007
- Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapyNature Biotechnology, 2005
- Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cellsNature Immunology, 2005
- Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cellsBlood, 2004
- Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+T-Cell Function in Melanoma PatientsJournal of Clinical Oncology, 2003
- Selective imprinting of gut-homing T cells by Peyer's patch dendritic cellsNature, 2003
- The Role of PGE2in the Differentiation of Dendritic Cells: How Do Dendritic Cells Influence T‐Cell Polarization and Chemokine Receptor Expression?The International Journal of Cell Cloning, 2002
- Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte‐derived dendritic cellsImmunology, 2002
- Langerhans’ cells produce type IV collagenase (MMP‐9) following epicutaneous stimulation with haptensImmunology, 1997